Delivery Order SPE2DR25D2006-SPE2DR26F56JF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Rexulti 0.5 mg tablets (30-count units) with a ceiling value of $3,697.68. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of December 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Rexulti 2 mg tablets (30-count packages) with a ceiling value of $9,967.07. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Rexulti 2 mg tablets in a quantity of 30 units, with a ceiling value of $3,299.21. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rexulti 1 mg tablets (30-count) at a ceiling value of $5,400.39. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The contract is scheduled for ultimate completion on November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Rexulti 1 mg tablets in a quantity of 30 units, with a ceiling value of $3,796.30. This competitively awarded contract, which carries no set-aside designation, is classified as a firm fixed price delivery order and is scheduled for completion by December 2, 2025. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Rexulti 1 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,701.72. This is a non-set-aside competitive award with an ultimate completion date of October 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Rexulti 0.5 mg tablets (30-count) under a firm fixed-price contract valued at $3,994.81. This delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, represents a competitively awarded, non-set-aside procurement. The order is scheduled for completion by December 5, 2025, and will be fulfilled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Rexulti 1 mg tablets (30-count package) valued at $9,576.43 under a firm fixed-price contract. This non-set-aside award represents a competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Rexulti 1 mg tablets (30-count) with a ceiling value of $19,213.48. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Rexulti 2 mg tablets in a quantity of 30 units, with a ceiling value of $9,482.33. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 1, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56JFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Rexulti 0.5 mg tablets (30-count) with a ceiling value of $9,382.23. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 1, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's ability to compete in open federal procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad range of medications, medical devices, and healthcare commodities to support military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency demonstrates its established capability to deliver specialty medications and brand-name pharmaceuticals across multiple therapeutic domains to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 11/27/25 |